Sycamore Biopharma
Columbia, US · Founded 2018 · South Carolina corporation
Founders & leadership
HL
H. Lee Mashburn, Jr.Named on SEC filing
WL
William LamarNamed on SEC filing
CS
Chris SadekNamed on SEC filing
RT
R. Tyler Stone IIINamed on SEC filing
MT
Mark T HamannNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 of 2 rounds · 2019–2021
▶$175KofferedMar 2021 · BiotechnologyRule 506(b)
▶$175KofferedMar 2021 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chris SadekDirector
- William LamarExecutive Officer, Director
- Mark T. HamannExecutive Officer, Director
- R. Tyler Stone IIIExecutive Officer, Director
- H. Lee Mashburn, Jr.Executive Officer, Director
- Offering amount
- $175K
- Minimum investment
- $25K
- Incorporated
- Corporation, South Carolina, 2018
- Federal exemptions
- 06b
▶$500KraisedDec 2019 · 5 investors · BiotechnologyRule 506(b)
▶$500KraisedDec 2019 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- H. Lee Mashburn, Jr.Executive Officer, Director
- William LamarExecutive Officer, Director
- Chris SadekDirector
- R. Tyler Stone IIIExecutive Officer, Director
- Mark T HamannExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- Minimum investment
- $100K
- First sale
- Dec 2019
- Incorporated
- Corporation, South Carolina, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Sycamore Biopharma raised?
- Sycamore Biopharma has disclosed $500K raised across 1 of its 2 known rounds.
- Where is Sycamore Biopharma headquartered?
- Sycamore Biopharma is headquartered in Columbia, US.